MassRoots closes $150,000 in seed investment from members of ArcView Group

NewsGuard 100/100 Score

MassRoots, the social network for the medical cannabis community, is pleased to announce it has closed $150,000 in seed investment from members of the ArcView Group. The funding comes on the heels of MassRoots surpassing 25,000 active users and facilitating more than 28 million photo views in the month of December alone.

"We're thrilled to welcome a diverse group of top-tier investors to the MassRoots team," stated Co-Founder Isaac Dietrich. "We look forward to their insight and strategic guidance as we scale MassRoots to hundreds of thousands of users."

With Colorado becoming the first state in the nation to legalize the recreational use of marijuana, investors across the country are looking to profit off what ArcView Research recently found to be, "The Fastest Growing Industry in America." Unlike most investment opportunities in the cannabis industry, MassRoots is an ancillary business -- it never touches marijuana itself -- making it a far less risky investment than a dispensary or grow operation. 

Launched in July 2013, MassRoots is an App-based social network dedicated entirely to high-quality cannabis content. Unlike other social networks, MassRoots does not require a users' name, email or phone number to join -- giving users a level of privacy and anonymity.

"By creating a network for the cannabis community, MassRoots is connecting tens of thousands of marijuana consumers, building a marketing and distribution channel for legal cannabis, and empowering the legalization movement itself," stated Co-Founder Isaac Dietrich. "In the process, we are creating a unique and valuable company that will deliver substantial returns to its shareholders."

SOURCE MassRoots

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Heavy cannabis use linked to increased risk of developing a new anxiety disorder